Do we need to stratify follicular lymphoma (FL) patients for treatment?
CLL11 trial shows improved OS rates in CLL with obinutuzumab
The importance of venetoclax in treating CLL
Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib
Key questions to be discussed at iwCLL 2017: cancer genetics, immunology and categorizing patients